Benitec Biopharma Inc.
BNTC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001808898
No open-market purchases or sales by Benitec Biopharma Inc. insiders were filed in the last 90 days; 86 institutions reported holding it in 13F filings for Q2 2026, worth $443.3M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Benitec Biopharma Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- +1 vs. Q1 2022
- Shares held
- 1.34M
- −242.0K (−15.3%) vs. Q1 2022
- Total value
- $1.55M
- −$1.05M (−40.3%) vs. Q1 2022
- New holders
- 5
- 8 more added
- Sold out
- 4
- 2 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BNTC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 86 | $443.3M |
| Q1 2026 | 88 | $346.0M |
| Q4 2025 | 72 | $426.6M |
| Q3 2025 | 56 | $324.7M |
| Q2 2025 | 57 | $265.3M |
| Q1 2025 | 37 | $290.1M |
| Q4 2024 | 30 | $240.2M |
| Q3 2024 | 25 | $126.8M |
| Q2 2024 | 19 | $44.3M |
| Q1 2024 | 13 | $6.58M |
| Q4 2023 | 13 | $3.88M |
| Q3 2023 | 12 | $3.84M |
| Q2 2023 | 17 | $2.45M |
| Q1 2023 | 21 | $2.44M |
| Q4 2022 | 25 | $2.09M |
| Q3 2022 | 25 | $5.92M |
| Q2 2022 | 22 | $1.55M |
| Q1 2022 | 21 | $2.60M |
| Q4 2021 | 17 | $4.16M |
| Q3 2021 | 19 | $5.43M |
| Q2 2021 | 18 | $6.46M |
| Q1 2021 | 15 | $1.84M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Benitec Biopharma Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Suvretta Capital Management, LLC | 769,000 | $892.0K | 0.03% | 00.0% | Unchanged |
| Barclays PLC | 136,307 | $158.0K | 0.00% | +77,612+132.2% | Added |
| Vanguard Group Inc | 78,371 | $91.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 60,481 | $70.0K | 0.00% | +915+1.5% | Added |
| Susquehanna International Group, LLP | 53,886 | $62.0K | 0.00% | +53,886 | New |
| Citadel Advisors LLC | 49,964 | $58.0K | 0.00% | +49,964 | New |
| Virtu Financial LLC | 47,393 | $55.0K | 0.00% | +47,393 | New |
| Millennium Management LLC | 25,132 | $29.0K | 0.00% | +25,132 | New |
| Two Sigma Securities, LLC | 24,270 | $28.0K | 0.00% | +24,270 | New |
| State Street Corp | 21,438 | $25.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 14,831 | $17.0K | 0.00% | −101−0.7% | Reduced |
| WealthTrust Axiom LLC | 12,950 | $15.0K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 11,813 | $14.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 11,916 | $13.0K | 0.00% | +11,569+3,334.0% | Added |
| Morgan Stanley | 5,800 | $7.00K | 0.00% | +5,700+5,700.0% | Added |
| Simplex Trading, LLC | 6,199 | $7.00K | 0.00% | +6,099+6,099.0% | Added |
| Tower Research Capital LLC (TRC) | 3,848 | $4.00K | 0.00% | +2,254+141.4% | Added |
| Citigroup Inc | 3,440 | $4.00K | 0.00% | +3,428+28,566.7% | Added |
| Group One Trading, L.P. | 2,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 47 | $0 | 0.00% | +4+9.3% | Added |
| Fieldpoint Private Securities, LLC | 3 | $0 | 0.00% | −6−66.7% | Reduced |
| Rockefeller Capital Management L.P. | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Atom Investors LP | 0 | $0 | 0.00% | −37,335−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −492,880−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −19,554−100.0% | Sold out |
| Rosenberg Matthew Hamilton | 0 | $0 | 0.00% | −381−100.0% | Sold out |